November 2

HOUSTON, November 2, 2011 - Endeavour International Corporation (NYSE: END) (LSE: ENDV) today reported adjusted EBITDA for the third quarter of 2011 was $2.4 million compared to $8.2 million in the third quarter of 2010 and $7.6 million in the second quarter of 2011.

ABU DHABI, UAE, November 2, 2011 - Additional 6,200 schools needed to fill growing student population that will reach 11.3 million in private and public schools in 2020 The private education sector in the GCC is poised for a massive surge, according to experts and analysts who gathered at the recently concluded Building Future Education MENA 2011.

DUBAI, UAE, November 2, 2011 - It's not often an e-mail reduces a grown man to tears of happiness.

MUNICH, November 2, 2011 - - Speakers at Medical Biodefense Conference Present Compelling Data Showing PLEX-ID Detects 17 Different Biothreat Pathogens Abbott's PLEX-ID system provides reliable and rapid results for key microbial biothreat agents and should be considered as a first line analytical tool for biodefense, biosecurity and microbial forensics programs, according to research presented at the 13th Medical Biodefense Conference in Munich.

BARCELONA, Spain, November 2, 2011 - In preparation for its European launch of Benlysta, the first FDA approved Lupus drug in 50 years, Human Genome Sciences (HGS) needed a customer relationship management (CRM) system to arm its newly formed European commercial sales team.